Digital and disrupted: All change for healthcare
How can pharma companies flourish in a digitized healthcare world?
The results are back and the prognosis is excellent: The digital health industry will grow at an average of 21 percent per year though to 2020. A healthy diet of large investments, young start-ups and favorable policy making is contributing to the multi-billion dollar industry's growth spurt. In Roland Berger's recent publication "Digital and disrupted: All change for healthcare", the role of key stakeholders in the healthcare systems of the future receives an in-depth examination.
Competition is expected to be fierce and new players are challenging traditional business models. A range of diagnostic tools and data will support medical treatment in the future. Within the various segments, mobile health applications are leading the way and annual growth rates of more than 40 percent are forecast. Apps have the potential to transform the way we diagnose disease. It will become possible to detect certain illnesses by measuring general health related data, like blood pressure, body temperature, sleeping habits and more.
What impact will digitization have on the healthcare industry? This interview with Roland Berger Partner Thilo Kaltenbach reveals insights into the unfolding possibilities.
Every company in the health market is affected by the digital transformation, as are doctors, pharmacies, patients and governments. Companies will have to choose the right business model to operate optimally in the digital health environment of the future. In an industry forecast to be worth more than 200 billion dollars by 2020 – comprehensive and diligent implementation of revolutionary digital technology are doctor's orders.
How can pharma companies flourish in a digitized healthcare world?